Emily Bernstein

Emily Bernstein

Icahn School of Medicine at Mount Sinai

H-index: 44

North America-United States

About Emily Bernstein

Emily Bernstein, With an exceptional h-index of 44 and a recent h-index of 36 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of chromatin, epigenetics, cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation

Abstract PR004: SMARCAL1 is a selective dependency and a novel synthetic lethal target in ATRX/DAXX mutant ALT+ osteosarcoma and neuroblastoma

MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming

LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

C. David Allis (1951–2023)

H2A. Z chaperones converge on histone H4 acetylation for melanoma cell proliferation

Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping

Emily Bernstein Information

University

Position

Professor, Mount Sinai

Citations(all)

37531

Citations(since 2020)

8821

Cited By

31959

hIndex(all)

44

hIndex(since 2020)

36

i10Index(all)

62

i10Index(since 2020)

60

Email

University Profile Page

Icahn School of Medicine at Mount Sinai

Google Scholar

View Google Scholar Profile

Emily Bernstein Skills & Research Interests

chromatin

epigenetics

cancer

Top articles of Emily Bernstein

Title

Journal

Author(s)

Publication Date

Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation

JCI insight

Karen Mendelson

Tiphaine C Martin

Christie B Nguyen

Min Hsu

Jia Xu

...

2024/3/22

Abstract PR004: SMARCAL1 is a selective dependency and a novel synthetic lethal target in ATRX/DAXX mutant ALT+ osteosarcoma and neuroblastoma

Cancer Research

Monika Wierdl

Jerrel L Catlett

Nicole Ocasio-Martinez

John D Johnson Jr

Amy Herman

...

2024/1/9

MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming

Communications Biology

Wazim Mohammed Ismail

Amelia Mazzone

Flavia G Ghiraldini

Jagneet Kaur

Manvir Bains

...

2023/2/23

LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

EMBO Molecular Medicine

Sarah Proteau

Imène Krossa

Chrystel Husser

Maxime Guéguinou

Federica Sella

...

2023/12/7

C. David Allis (1951–2023)

Molecular cell

Emily Bernstein

Sharon Dent

Yali Dou

Elizabeth M Duncan

Sandra B Hake

...

2023/2/16

H2A. Z chaperones converge on histone H4 acetylation for melanoma cell proliferation

bioRxiv

Sina Jostes

Chiara Vardabasso

Joanna Dong

Saul Carcamo

Rajendra Singh

...

2023/11/26

Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

nature communications

Royce W Zhou

Jia Xu

Tiphaine C Martin

Alexis L Zachem

John He

...

2023

MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping

Nature Cell Biology

Dan Filipescu

Saul Carcamo

Aman Agarwal

Navpreet Tung

Étienne Humblin

...

2023/9

Sustained CD28 costimulation is required for self-renewal and differentiation of TCF-1+ PD-1+ CD8 T cells

Science immunology

Etienne Humblin

Isabel Korpas

Jiahua Lu

Dan Filipescu

Verena van der Heide

...

2023/8/25

5-Azacytidine-and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling

Cell reports

Deepak K Singh

Saul Carcamo

Eduardo F Farias

Dan Hasson

Wei Zheng

...

2023/6/27

A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma (vol 13, 6041, 2022)

Cancer Research

Royce Zhou

Jia Xu

Tiphaine Martin

Alexis Zachem

John He

...

2023/4/4

Epigenetic Regulation of the Melanoma Microenvironment

Emily Bernstein

2022/9/1

CD28 signaling strength regulates the cell fate of TCF-1+ PD-1+ CD8 T cells

The Journal of Immunology

Etienne Humblin

Verena Van der Heide

Dan Filipescu

Ashley Lu

Myvizhi Selvan

...

2022/5/1

Loss of PBRM1 alters promoter histone modifications and activates ALDH1A1 to drive renal cell carcinoma

Molecular Cancer Research

David A Schoenfeld

Royce Zhou

Sakellarios Zairis

William Su

Nicole Steinbach

...

2022/8/5

Altered BAF occupancy and transcription factor dynamics in PBAF-deficient melanoma

Cell reports

Saul Carcamo

Christie B Nguyen

Elena Grossi

Dan Filipescu

Aktan Alpsoy

...

2022/4/5

Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells

The Journal of clinical investigation

Peng Wang

Esra Karakose

Carmen Argmann

Huan Wang

Metodi Balev

...

2022/8/1

CD28 signaling controls maintenance and differentiation of PD1+CD8 T cells during chronic antigen stimulation

Cancer Research

Etienne Humblin

Verena Van der Heide

Dan Filipescu

Ashley Lu

Alessandra Soares-Schanoski

...

2022/6/15

MacroH2A impedes metastatic growth by enforcing a discrete dormancy program in disseminated cancer cells

Science Advances

Dan Sun

Deepak K Singh

Saul Carcamo

Dan Filipescu

Bassem Khalil

...

2022/12/2

MacroH2A restricts melanoma progression via inhibition of inflammatory gene expression in cancer-associated fibroblasts

Dan Filipescu

Dan Hasson

Navpreet Tung

Saul Carcamo

Etienne Humblin

...

2022/5/5

Compounds and methods for inhibiting cancers via rest inhibition

2022/9/22

See List of Professors in Emily Bernstein University(Icahn School of Medicine at Mount Sinai)